Clinical Outcomes

FACT supports blood and marrow transplant (BMT) programs’ efforts to evaluate one-year survival data to improve patient outcomes, advance the field, and maintain payer and public confidence. FACT requires programs to submit a corrective action plan when one-year survival does not at least meet expected outcomes as demonstrated in comparative data. Several resources are available to assist programs with identifying trends in cause of death, the root causes, and corrective and preventive actions.

Comparative Data Sources

The following are acceptable data sources for benchmarking one-year survival:

U.S. Allogeneic Programs
CIBMTR Transplant Center-Specific Survival Report

Autologous Programs and Non-U.S. Programs
C.W. Bill Young Cell Transplantation Program’s U.S. Patient Survival Report

Be the Match/NMDP Disease-Specific HCT Indications and Outcomes Data

Country or region-specific registries

Peer-reviewed Medical Literature

Educational Resources

FACT QM Series Module 7: Outcome Analysis

FACT Inspection & Accreditation Workshops

ASBMT Committee on Quality Outcomes

Guidelines for Corrective Action Plans

The FACT Clinical Outcomes Improvement Committee reviews corrective action plans using specific criteria.

Corrective action plans must:

  • Must identify specific causes of death
  • Must provide quantitative data
  • Must identify reasonable causes of the low one-year survival rate
  • Must address the identified causes
  • Must be a measurable outcome improvement
  • Must provide updates at the time of annual reporting, and as otherwise directed by committee

Example Corrective Action Plans

Allogeneic

Autologous


Ask FACT

FAQ

Ask a Peer
FACT Consulting

Accreditation Success Story

Hoxworth Blood Center Apheresis Collection Facility and its Cellular Therapies Division have been accredited by FACT since 2003. The program values their FACT accreditation and the impact it has had on their program’s continuous quality improvement objectives. Read more